Baylor University Medical Center
Dallas, Texas, 752245, United States
NCT Number: NCT01525797
The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.
Looking for future studies?
Notify Me17 year–65 year
All sexes
Observational
Dallas, Texas, 752245, United States
The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Analyze the pattern of gene expression in patients undergoing solid organ transplantation
Baylor Research Institute
Other
Immunomonitoring of Transplant Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05077254
COVID-19, Coronaviridae Infections
San Diego, California, United States
View Trial DetailsNCT01638559
Immunosuppression, Liver Transplant Recipients
San Francisco, California, United States
View Trial DetailsNCT02482974
Liver Transplant Recipients
Izmir, Turkey (Türkiye)
View Trial DetailsNCT02320422
Behavior, Health Behavior
New York, United States
View Trial Details